Childhood Brain Stem Glioma Treatment (PDQ®)–Health Professional Version
SECTIONS
- General Information About Childhood Brain Stem Glioma
- Cellular Classification of Childhood Brain Stem Glioma
- Stage Information for Childhood Brain Stem Glioma
- Treatment Option Overview for Childhood Brain Stem Glioma
- Newly Diagnosed Childhood Brain Stem Glioma Treatment
- Progressive/Recurrent Childhood Brain Stem Glioma Treatment
- Changes to This Summary (01/24/2018)
- About This PDQ Summary
- View All Sections
Changes to This Summary (01/24/2018)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Added text to state that reirradiation has been shown to prolong survival and can be considered at first progression in children who have had an initial response to radiation therapy (cited Janssens et al. as reference 1).
Added text to state that patients with a brain stem glioma may be enrolled on the APEC1621 trial if tissue is available from a diagnostic biopsy.
This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
No hay comentarios:
Publicar un comentario